For instance, the estrogen receptor could be modulated by a range of compounds, such as ellagic acid, coniferin, and leucopelargonidin, suggesting that the active compounds derived from QFHXD might effectively treat pulmonary fibrosis through multiple targets. The gene discussed is ESR1; the disease is pulmonary fibrosis.